Literature DB >> 32851538

Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.

Eleonora Del Prete1, Luca Tommasini1, Sonia Mazzucchi1, Daniela Frosini2, Giovanni Palermo1, Riccardo Morganti3, Cristina Pagni1, Gloria Tognoni2, Ubaldo Bonuccelli1, Roberto Ceravolo4.   

Abstract

BACKGROUND: Progressive supranuclear palsy (PSP) is an atypical Parkinsonism characterized by motor and neuropsycological disorders. Language could be impaired in PSP patients, also in Richardson variant (PSP-RS). The analysis of connected speech is used in neurodegenerative disorder to investigate different levels of language organization, including phonetic, phonological, lexico-semantic, morpho-syntactic, and pragmatic processing.
OBJECTIVE: In our study, we aimed to investigate the language profile, especially connected speech, in early-stage PSP-RS and Parkinson's disease (PD) patients without predominant speech or language disorders.
METHODS: Language was assessed using the Screening for Aphasia in NeuroDegeneration (SAND); connected speech analysis was conducted from the picture description subtest.
RESULTS: We enrolled 48 patients, 22 PD and 26 PSP (18 PSP-RS and 8 non-RS). PSP-RS patients presented an impairment in language domain, particularly regarding connected speech. PSP-RS patients presented worse performances than PD in different scores. The output of PSP-RS patients was characterized by a reduction in number of sentences and subordinates with respect to PD; PSP presented also more repaired sequences and phonological and lexico-semantic errors than PD. Number of sentences and number of subordinates of the picture description task were identified as predictors of PSP diagnosis.
CONCLUSION: In summary, the SAND scale is able to identify language impairment in PSP patients. The analysis of connected speech could highlight some important aspects of language impairment in PSP-RS patients, and it could be helpful in the differential diagnosis with PD.

Entities:  

Keywords:  Connected speech; Language; Progressive supranuclear palsy; SAND

Mesh:

Year:  2020        PMID: 32851538     DOI: 10.1007/s10072-020-04635-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

Review 1.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

2.  The language profile of progressive supranuclear palsy.

Authors:  Eleonora Catricalà; Veronica Boschi; Sofia Cuoco; Francesco Galiano; Marina Picillo; Elena Gobbi; Antonio Miozzo; Cristiano Chesi; Valentina Esposito; Gabriella Santangelo; Maria Teresa Pellecchia; Virginia M Borsa; Paolo Barone; Peter Garrard; Sandro Iannaccone; Stefano F Cappa
Journal:  Cortex       Date:  2019-02-22       Impact factor: 4.027

3.  Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Authors:  Richard G Brown; Lucette Lacomblez; Bernard G Landwehrmeyer; Thomas Bak; Ingo Uttner; Bruno Dubois; Yves Agid; Albert Ludolph; Gilbert Bensimon; Christine Payan; Nigel P Leigh
Journal:  Brain       Date:  2010-06-24       Impact factor: 13.501

4.  Progressive supranuclear palsy presenting with dynamic aphasia.

Authors:  T Esmonde; E Giles; J Xuereb; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  Dynamic aphasia in progressive supranuclear palsy: a deficit in generating a fluent sequence of novel thought.

Authors:  Gail Robinson; Tim Shallice; Lisa Cipolotti
Journal:  Neuropsychologia       Date:  2006-02-28       Impact factor: 3.139

6.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

7.  Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  E R Maher; E M Smith; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

8.  The 'subcortical dementia' of progressive supranuclear palsy.

Authors:  M L Albert; R G Feldman; A L Willis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-02       Impact factor: 10.154

9.  Frontal dynamic aphasia in progressive supranuclear palsy: Distinguishing between generation and fluent sequencing of novel thoughts.

Authors:  Gail A Robinson; Donna Spooner; William J Harrison
Journal:  Neuropsychologia       Date:  2015-08-04       Impact factor: 3.139

10.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.